Investigation and comparison of sedative effects of ketofol and midazolam-ketamine combination in endoscopy

Investigation and comparison of sedative effects of ketofol and midazolam-ketamine combination in endoscopy of upper gastrointestinal tract in children 1 to 14 years

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200620047853N1

Enrollment

Registered

2020-06-22

Start date

2014-08-23

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endoscopy. During endoscopic examination

Interventions

Intervention 1: Intervention group: Use of 1 mg /kg ketamine and 1 mg /kg propofol. Intervention 2: Control group: Use of 0.05 mg / kg midazolam and 2 mg / kg ketamine at.

Eligibility

Sex/Gender

All

Age

1 Years to 14 Years

Inclusion criteria

Inclusion criteria: Candidate for endoscopy Age 1 to 14 years old

Exclusion criteria

Exclusion criteria: Cardiopulmonary disease

Design outcomes

Primary

Measure	Time frame
Systolic blood pressure. Timepoint: Before and 5, 10, 30 and 60 minutes after sedation. Method of measurement: Barometer.;Diastolic blood pressure. Timepoint: Before and 5, 10, 30 and 60 minutes after sedation. Method of measurement: Barometer.	—

Secondary

Measure	Time frame
Heart rate. Timepoint: Before and 5, 10, 30 and 60 minutes after sedation. Method of measurement: Heart rate count.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactVahid Adiban

Ardabil University of Medical Sciences

v.adiban@arums.ac.ir+98 45 3325 1401

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026